{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:53:11Z","timestamp":1781542391886,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100021077","name":"Vice Chancellor for Research and Technology, Kerman University of Medical Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021077","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04455-w","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:49:25Z","timestamp":1781534965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential expression of NEAT1 and miR-506-3p in triple-negative breast cancer: potential tissue-based diagnostic biomarkers"],"prefix":"10.1007","author":[{"given":"Mohammad","family":"Samani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Samareh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliasghar","family":"Tirgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Akrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Moazed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Pourghadamyari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9529-4077","authenticated-orcid":false,"given":"Mohammad Hadi","family":"Nematollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"4455_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2020","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast. 2020;66:15\u201323.","journal-title":"Breast"},{"issue":"8","key":"4455_CR2","doi-asserted-by":"publisher","first-page":"13726","DOI":"10.1002\/jcb.28645","volume":"120","author":"P Paydar","year":"2019","unstructured":"Paydar P, Asadikaram G, Nejad HZ, Akbari H, Abolhassani M, Moazed V, et al. Epigenetic modulation of BRCA\u20101 and MGMT genes, and histones H4 and H3 are associated with breast tumors. J Cell Biochem. 2019;120(8):13726\u201336.","journal-title":"J Cell Biochem"},{"key":"4455_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03502-3","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025. https:\/\/doi.org\/10.1038\/s41591-025-03502-3.","journal-title":"Nat Med"},{"issue":"2","key":"4455_CR4","first-page":"39","volume":"4","author":"M Yarahmadi","year":"2018","unstructured":"Yarahmadi M, Heidarirad H, Shafiei M. Evaluation of prevalence of depression and its related factors among women with breast cancer referred to the Radiotherapy Center of Tawhid Hospital of Sanandaj, Iran in 2017. Sci J Nurs Midwifery Paramed Fac. 2018;4(2):39\u201349.","journal-title":"Sci J Nurs Midwifery Paramed Fac"},{"issue":"19","key":"4455_CR5","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci. 2001;98(19):10869\u201374.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"4455_CR6","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1038\/s41598-025-88394-6","volume":"15","author":"ME Lacruz","year":"2025","unstructured":"Lacruz ME, Thies S, Schmidt-Pokrzywniak A, Wittenberg I, Engler T, Reinwald F, et al. Clinical characteristics, metastasis patterns, and treatment outcomes of HER2-low breast cancer. Sci Rep. 2025;15(1):4584.","journal-title":"Sci Rep"},{"issue":"1","key":"4455_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/PAP.0000000000000232","volume":"27","author":"JY Tsang","year":"2020","unstructured":"Tsang JY, Gary MT. Molecular classification of breast cancer. Adv Anat Pathol. 2020;27(1):27\u201335.","journal-title":"Adv Anat Pathol"},{"issue":"8","key":"4455_CR8","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","volume":"22","author":"A Goldhirsch","year":"2011","unstructured":"Goldhirsch A, Wood WC, Coates AS, Gelber RD, Th\u00fcrlimann B, Senn H-J. Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol. 2011;22(8):1736\u201347.","journal-title":"Ann Oncol"},{"issue":"1","key":"4455_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/medicina57010062","volume":"57","author":"SA Dass","year":"2021","unstructured":"Dass SA, Tan KL, Selva Rajan R, Mokhtar NF, Mohd Adzmi ER, Wan Abdul Rahman WF, et al. Triple negative breast cancer: a review of present and future diagnostic modalities. Medicina. 2021;57(1):62.","journal-title":"Medicina"},{"issue":"2","key":"4455_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12966","volume":"54","author":"W Zhang","year":"2021","unstructured":"Zhang W, Guan X, Tang J. The long non-coding RNA landscape in triple-negative breast cancer. Cell Prolif. 2021;54(2):e12966.","journal-title":"Cell Prolif"},{"issue":"2","key":"4455_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1136\/jclinpath-2021-207487","volume":"75","author":"E Rakha","year":"2022","unstructured":"Rakha E, Toss M, Quinn C. Specific cell differentiation in breast cancer: a basis for histological classification. J Clin Pathol. 2022;75(2):76\u201384.","journal-title":"J Clin Pathol"},{"issue":"1","key":"4455_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s43042-024-00553-y","volume":"25","author":"TP George","year":"2024","unstructured":"George TP, Subramanian S, Supriya M. A brief review of noncoding RNA. Egypt J Med Human Genet. 2024;25(1):98.","journal-title":"Egypt J Med Human Genet"},{"issue":"22","key":"4455_CR13","doi-asserted-by":"publisher","first-page":"16213","DOI":"10.3390\/ijms242216213","volume":"24","author":"R Be\u0148a\u010dka","year":"2023","unstructured":"Be\u0148a\u010dka R, Szab\u00f3ov\u00e1 D, Gu\u013ea\u0161ov\u00e1 Z, Hertelyov\u00e1 Z, Rado\u0148ak J. Non-coding RNAs in human cancer and other diseases: overview of the diagnostic potential. Int J Mol Sci. 2023;24(22):16213.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4455_CR14","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1073\/pnas.0707594105","volume":"105","author":"RF Place","year":"2008","unstructured":"Place RF, Li L-C, Pookot D, Noonan EJ, Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci. 2008;105(5):1608\u201313.","journal-title":"Proc Natl Acad Sci"},{"key":"4455_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.526850","volume":"10","author":"SR Volovat","year":"2020","unstructured":"Volovat SR, Volovat C, Hordila I, Hordila D-A, Mirestean CC, Miron OT, et al. MiRNA and LncRNA as potential biomarkers in triple-negative breast cancer: a review. Front Oncol. 2020;10:526850.","journal-title":"Front Oncol"},{"key":"4455_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114672","volume":"162","author":"B Ma","year":"2023","unstructured":"Ma B, Wang S, Wu W, Shan P, Chen Y, Meng J, et al. Mechanisms of circRNA\/lncRNA-miRNA interactions and applications in disease and drug research. Biomed Pharmacother. 2023;162:114672.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"4455_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007851","volume":"16","author":"J Zhang","year":"2020","unstructured":"Zhang J, Xu T, Liu L, Zhang W, Zhao C, Li S, et al. LMSM: a modular approach for identifying lncRNA related miRNA sponge modules in breast cancer. PLoS Comput Biol. 2020;16(4):e1007851.","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"4455_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/ncrna6040043","volume":"6","author":"G Pisani","year":"2020","unstructured":"Pisani G, Baron B. NEAT1 and paraspeckles in cancer development and chemoresistance. Non-coding RNA. 2020;6(4):43.","journal-title":"Non-coding RNA"},{"issue":"3","key":"4455_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.3993","volume":"42","author":"AA Alzahrani","year":"2024","unstructured":"Alzahrani AA, Saleh RO, Latypova A, Bokov DO, Kareem AH, Talib HA, et al. Therapeutic significance of long noncoding RNAs in estrogen receptor-positive breast cancer. Cell Biochem Funct. 2024;42(3):e3993.","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"4455_CR20","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1038\/ncomms6383","volume":"5","author":"D Chakravarty","year":"2014","unstructured":"Chakravarty D, Sboner A, Nair SS, Giannopoulou E, Li R, Hennig S, et al. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun. 2014;5(1):5383.","journal-title":"Nat Commun"},{"issue":"13","key":"4455_CR21","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.7150\/ijbs.62728","volume":"17","author":"K Li","year":"2021","unstructured":"Li K, Yao T, Zhang Y, Li W, Wang Z. NEAT1 as a competing endogenous RNA in tumorigenesis of various cancers: Role, mechanism and therapeutic potential. Int J Biol Sci. 2021;17(13):3428.","journal-title":"Int J Biol Sci"},{"key":"4455_CR22","doi-asserted-by":"publisher","first-page":"6091","DOI":"10.2147\/CMAR.S252295","volume":"12","author":"S Li","year":"2020","unstructured":"Li S, Hao J, Hong Y, Mai J, Huang W. Long non-coding RNA NEAT1 promotes the proliferation, migration, and metastasis of human breast-cancer cells by inhibiting miR-146b-5p expression. Cancer Manag Res. 2020;12:6091\u2013101.","journal-title":"Cancer Manag Res"},{"issue":"38","key":"4455_CR23","doi-asserted-by":"publisher","first-page":"62778","DOI":"10.18632\/oncotarget.11294","volume":"7","author":"J Li","year":"2016","unstructured":"Li J, Ju J, Ni B, Wang H. The emerging role of miR-506 in cancer. Oncotarget. 2016;7(38):62778.","journal-title":"Oncotarget"},{"key":"4455_CR24","doi-asserted-by":"publisher","first-page":"1524763","DOI":"10.3389\/fonc.2025.1524763","volume":"15","author":"S Mao","year":"2025","unstructured":"Mao S, Li J, Huang J, Lv L, Zhang Q, Cheng Q, et al. Therapeutic potential of microRNA-506 in cancer treatment: mechanisms and therapeutic implications. Front Oncol. 2025;15:1524763.","journal-title":"Front Oncol"},{"issue":"11","key":"4455_CR25","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.3390\/biomedicines11112874","volume":"11","author":"T Yang","year":"2023","unstructured":"Yang T, Han Y, Chen J, Liang X, Sun L. MiR-506 promotes antitumor immune response in pancreatic cancer by reprogramming tumor-associated macrophages toward an M1 phenotype. Biomedicines. 2023;11(11):2874.","journal-title":"Biomedicines"},{"issue":"1","key":"4455_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12935-018-0642-8","volume":"18","author":"X-X Wang","year":"2018","unstructured":"Wang X-X, Guo G-C, Qian X-K, Dou D-W, Zhang Z, Xu X-D, et al. miR-506 attenuates methylation of lncRNA MEG3 to inhibit migration and invasion of breast cancer cell lines via targeting SP1 and SP3. Cancer Cell Int. 2018;18(1):171.","journal-title":"Cancer Cell Int"},{"issue":"4","key":"4455_CR27","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s13273-021-00160-7","volume":"17","author":"X Zhao","year":"2021","unstructured":"Zhao X, Bai X, Li W, Gao X, Wang X, Li B. microRNA-506-3p suppresses the proliferation of triple negative breast cancer cells via targeting SNAI2. Mol Cell Toxicol. 2021;17(4):513\u201322.","journal-title":"Mol Cell Toxicol"},{"issue":"36","key":"4455_CR28","doi-asserted-by":"publisher","first-page":"8214","DOI":"10.2174\/0109298673336756241016063552","volume":"32","author":"A Samareh","year":"2025","unstructured":"Samareh A, Nematollahi MH, Pourghadamyari H, Meimand HAE, Shabani M, Asadikaram G. Diagnostic Potential of NEAT1, hsa-let-7a-5p, and miR-506-3p in Early stage Parkinson\u2019s Disease. Curr Med Chem. 2025;32(36):8214\u201328.","journal-title":"Curr Med Chem"},{"key":"4455_CR29","doi-asserted-by":"crossref","unstructured":"Liu A, Xu X. MicroRNA isolation from formalin-fixed, paraffin-embedded tissues. Formalin-fixed paraffin-embedded tissues: methods and protocols: Springer; 2011. p. 259\u201367","DOI":"10.1007\/978-1-61779-055-3_16"},{"issue":"3","key":"4455_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s10495-018-1501-8","volume":"24","author":"A Mohammadpour-Gharehbagh","year":"2019","unstructured":"Mohammadpour-Gharehbagh A, Jahantigh D, Eskandari M, Sadegh MH, Nematollahi MH, Rezaei M, et al. Genetic and epigenetic analysis of the BAX and BCL2 in the placenta of pregnant women complicated by preeclampsia. Apoptosis. 2019;24(3):301\u201311.","journal-title":"Apoptosis"},{"issue":"3","key":"4455_CR31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3892\/ijmm.2017.3060","volume":"40","author":"L Zhou","year":"2017","unstructured":"Zhou L, Zhou W, Zhang H, Hu Y, Yu L, Zhang Y, et al. Progesterone suppresses triple-negative breast cancer growth and metastasis to the brain via membrane progesterone receptor \u03b1. Int J Mol Med. 2017;40(3):755\u201361.","journal-title":"Int J Mol Med"},{"issue":"3","key":"4455_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000433622","volume":"10","author":"F Marm\u00e9","year":"2015","unstructured":"Marm\u00e9 F, Schneeweiss A. Targeted therapies in triple-negative breast cancer. Breast Care (Basel). 2015;10(3):159\u201366.","journal-title":"Breast Care (Basel)"},{"issue":"1","key":"4455_CR33","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.18632\/aging.202254","volume":"13","author":"Y Huang","year":"2021","unstructured":"Huang Y, Wang X, Zheng Y, Chen W, Zheng Y, Li G, et al. Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer. Aging (Albany NY). 2021;13(1):1153\u201375.","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"4455_CR34","first-page":"745","volume":"55","author":"Y Pang","year":"2019","unstructured":"Pang Y, Wu J, Li X, Wang C, Wang M, Liu J, et al. NEAT1\/miR-124\/STAT3 feedback loop promotes breast cancer progression. Int J Oncol. 2019;55(3):745\u201354.","journal-title":"Int J Oncol"},{"issue":"9","key":"4455_CR35","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1007\/s43032-021-00481-x","volume":"28","author":"S Thankachan","year":"2021","unstructured":"Thankachan S, Bhardwaj BK, Venkatesh T, Suresh PS. Long non-coding RNA NEAT1 as an emerging biomarker in breast and gynecologic cancers: a systematic overview. Reprod Sci. 2021;28(9):2436\u201347.","journal-title":"Reprod Sci"},{"issue":"5","key":"4455_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.2174\/2211536609666201209152949","volume":"9","author":"GS El Din","year":"2020","unstructured":"El Din GS, Youness RA, Assal RA, Gad MZ. MiRNA-506-3p directly regulates rs10754339 (A\/G) in the immune checkpoint protein B7-H4 in breast cancer. MicroRNA. 2020;9(5):346\u201353.","journal-title":"MicroRNA"},{"key":"4455_CR37","doi-asserted-by":"publisher","first-page":"vi28","DOI":"10.1093\/annonc\/mdy314.027","volume":"29","author":"GS El Din","year":"2018","unstructured":"El Din GS, Youness R, Assal R, Gad M. Mir-506\u20133p synergistically represses breast cancer progression through altering cell cycle regulators. Ann Oncol. 2018;29:vi28.","journal-title":"Ann Oncol"},{"issue":"10","key":"4455_CR38","first-page":"11531","volume":"13","author":"H Xu","year":"2021","unstructured":"Xu H, Luo M, Xiang H, Liao W, Huang H, Wu Y, et al. miR-506-3p can inhibit cell proliferation and is a diagnostic and prognostic marker of liver cancer. Am J Trans Res. 2021;13(10):11531.","journal-title":"Am J Trans Res"},{"key":"4455_CR39","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3389\/fonc.2020.00998","volume":"10","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Cheng Q, Xia M, Huang X, He X, Liao J. Hypoxia-induced lncRNA-NEAT1 sustains the growth of hepatocellular carcinoma via regulation of miR-199a-3p\/UCK2. Front Oncol. 2020;10:998.","journal-title":"Front Oncol"},{"issue":"4","key":"4455_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202100339","volume":"17","author":"H Shou","year":"2022","unstructured":"Shou H, Wu J, Tang N, Wang B. Calcification-based cancer diagnosis and therapy. ChemMedChem. 2022;17(4):e202100339.","journal-title":"ChemMedChem"},{"issue":"2","key":"4455_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/cncr.30281","volume":"123","author":"SJ Nyante","year":"2017","unstructured":"Nyante SJ, Lee SS, Benefield TS, Hoots TN, Henderson LM. The association between mammographic calcifications and breast cancer prognostic factors in a population-based registry cohort. Cancer. 2017;123(2):219\u201327.","journal-title":"Cancer"},{"issue":"2","key":"4455_CR42","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.18632\/oncotarget.13737","volume":"8","author":"C Yang","year":"2017","unstructured":"Yang C, Li Z, Li Y, Xu R, Wang Y, Tian Y, et al. Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis. Oncotarget. 2017;8(2):2672\u201380.","journal-title":"Oncotarget"},{"issue":"3","key":"4455_CR43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10549-022-06767-1","volume":"196","author":"H Vihervuori","year":"2022","unstructured":"Vihervuori H, Korpinen K, Autere T-A, Repo H, Talvinen K, Kronqvist P. Varying outcomes of triple-negative breast cancer in different age groups\u2013prognostic value of clinical features and proliferation. Breast Cancer Res Treat. 2022;196(3):471\u201382.","journal-title":"Breast Cancer Res Treat"},{"key":"4455_CR44","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S252295","author":"S Li","year":"2020","unstructured":"Li S, Hao J, Hong Y, Mai J, Huang W. Long non-coding RNA NEAT1 promotes the proliferation, migration, and metastasis of human breast-cancer cells by inhibiting miR-146b-5p expression. Cancer Manag Res. 2020. https:\/\/doi.org\/10.2147\/CMAR.S252295.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"4455_CR45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41419-019-1513-5","volume":"10","author":"VY Shin","year":"2019","unstructured":"Shin VY, Chen J, Cheuk IWY, Siu MT, Ho CW, Wang X, et al. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness. Cell Death Dis. 2019;10(4):270.","journal-title":"Cell Death Dis"},{"key":"4455_CR46","doi-asserted-by":"crossref","unstructured":"Yong W, Yu D, Jun Z, Yachen D, Weiwei W, Midie X, et al. Long noncoding RNA NEAT1, regulated by LIN28B, promotes cell proliferation and migration through sponging miR-506 in high-grade serous ovarian cancer. Cell Death Dis. 2018;9.9:861.","DOI":"10.1038\/s41419-018-0908-z"},{"issue":"4","key":"4455_CR47","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.bbrc.2016.11.120","volume":"482","author":"B Huang","year":"2017","unstructured":"Huang B, Liu C, Wu Q, Zhang J, Min Q, Sheng T, et al. Long non-coding RNA NEAT1 facilitates pancreatic cancer progression through negative modulation of miR-506-3p. Biochem Biophys Res Commun. 2017;482(4):828\u201334.","journal-title":"Biochem Biophys Res Commun"},{"issue":"16_suppl","key":"4455_CR48","doi-asserted-by":"publisher","first-page":"e12656-e","DOI":"10.1200\/JCO.2024.42.16_suppl.e12656","volume":"42","author":"H Eldib","year":"2024","unstructured":"Eldib H, Nwanwene K, Kachynski Y, Wright T, Abdallah M, Kumar L, et al. Predicting pathological response in early stage triple-negative breast cancer: exploring the role of BRCA gene mutations\u2014A retrospective single-institution study. J Clin Oncol. 2024;42(16_suppl):e12656-e.","journal-title":"J Clin Oncol"},{"issue":"2","key":"4455_CR49","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10549-013-2461-x","volume":"138","author":"C Liedtke","year":"2013","unstructured":"Liedtke C, Hess KR, Karn T, Rody A, Kiesel L, Hortobagyi GN, et al. The prognostic impact of age in patients with triple-negative breast cancer. Breast Cancer Res Treat. 2013;138(2):591\u20139.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"4455_CR50","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3390\/biomedicines13051100","volume":"13","author":"N Ramanan","year":"2025","unstructured":"Ramanan N, Malik MN, Upneja S, Farooq H, Kulkarni S, Gupta R, et al. Clinical significance of tumor grade in triple-negative breast cancer: a retrospective cohort analysis. Biomedicines. 2025;13(5):1100.","journal-title":"Biomedicines"},{"issue":"3","key":"4455_CR51","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/diseases11030118","volume":"11","author":"N Chintapally","year":"2023","unstructured":"Chintapally N, Englander K, Gallagher J, Elleson K, Sun W, Whiting J, et al. Tumor characteristics associated with axillary nodal positivity in triple negative breast cancer. Diseases. 2023;11(3):118.","journal-title":"Diseases"},{"key":"4455_CR52","doi-asserted-by":"publisher","first-page":"149638","DOI":"10.1016\/j.gene.2025.149638","volume":"964","author":"S Thankachan","year":"2025","unstructured":"Thankachan S, Kavitha KP, Eswaran S, Kabekkodu SP, Suresh PS. Expression of the lncRNA NEAT1\/hsa-miR-20b-5p\/STAT3 axis in breast cancer. Gene. 2025;964:149638.","journal-title":"Gene"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04455-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04455-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04455-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T16:04:32Z","timestamp":1781539472000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04455-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":52,"alternative-id":["4455"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04455-w","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}